The course, themed “Prognosis, Present, and Future,” focused on how new knowledge and technologies are modifying diagnostic and therapeutic possibilities. Key areas discussed included neonatal screening and gene therapy for rare diseases, thrombectomy in pediatric stroke, and functional surgery for epilepsy and movement disorders.
Early detection through neonatal and genomic screening allows for the identification of rare diseases from the earliest moments of life, while the development of gene therapy offers curative options for conditions that previously lacked treatment.
Dr. Belén Pérez, course director, highlights the significance of pediatric stroke and Vall d’Hebron's role as Catalonia's sole reference center for stroke emergencies, enabling thrombectomy to improve neurological sequelae.
Functional or stereotactic surgery for movement disorders and epilepsy, a minimally invasive technique, was also a central theme. These advancements exemplify the transformation of pediatric neurology through innovation.
Vall d’Hebron is consolidating its position as a reference center in these fields, leading clinical trials in advanced therapies and translating research into patient care.
